Hyperbaric oxygen treatment: Results in seven patients with severe bacterial postoperative central nervous system infections and refractory mucormycosis | Canada Hyperbarics Skip to main content
Case Report Diving Hyperb Med 2021

Hyperbaric oxygen treatment: Results in seven patients with severe bacterial postoperative central nervous system infections and refractory mucormycosis

Valente Aguiar P, Carvalho B, Monteiro P, Linhares P, Camacho Ó, Vaz R — Diving Hyperb Med, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Portuguese neurosurgeons reviewed outcomes for seven patients with treatment-resistant infections of the brain or spine, including post-surgical bacterial infections and spontaneous fungal infections (mucormycosis), who received HBOT after an average of four prior operations and five months of antibiotics had failed.

What They Found

Six of seven patients achieved infection resolution after completing HBOT. The one patient who stopped after 3 sessions due to intolerance did not resolve. Three patients discontinued antimicrobials entirely; four continued on preventive doses. Median follow-up was 20 months.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

Seven patients in a retrospective case series is too small to draw firm conclusions, and the absence of a control group makes it impossible to know how many patients might have resolved without HBOT.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 33761547
Year Published 2021
Journal Diving Hyperb Med
MeSH Terms Humans; Hyperbaric Oxygenation; Middle Aged; Mucormycosis; Oxygen Inhalation Therapy; Retrospective Studies; Treatment Outcome

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology